AAOMS Annual Meeting

The US Food and Drug Administration has expanded a 2017 contraindication for opioid-containing cough and cold products, which initially only restricted their use in children younger than 12 years.

The US Food and Drug Administration has approved a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the improvement of glycemic control in adults with type 2 diabetes.

The US Food and Drug Administration has approved a new option to treat dangerously low blood pressure in adult patients with septic or other distributive shock.

The US Food and Drug Administration has approved a new option to treat dangerously low blood pressure in adult patients with septic or other distributive shock.

The US Food and Drug Administration has approved a new option to treat dangerously low blood pressure in adult patients with septic or other distributive shock.

The US Food and Drug Administration has approved a new treatment option for patients with open-angle glaucoma or ocular hypertension.

The US Food and Drug Administration has approved a new treatment option for patients with open-angle glaucoma or ocular hypertension.

The US Food and Drug Administration has approved a new treatment option for patients with open-angle glaucoma or ocular hypertension.

The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.

The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.